Inventor · disambiguated record
Matthew G. Stanton
Also filed as: STANTON MATTHEW · STANTON MATTHEW G · STANTON MATTHEW L
72 granted patents·32 pending applications·773 citations·filing 1999–2025
99Inventor score
Files withSIRNA THERAPEUTICS INC30GENERATION BIO CO19MODERNATX INC16MERCK SHARP & DOHME9MERCK & CO INC5
Top patents by PatentIndex Score
104 records- 0198US10286086B2Alternative nucleic acid molecules and uses thereofMODERNATX INC·Filed 2015·Granted May 14, 2019·78 cites·14 claims
- 0298US9604908B2Diether based biodegradable cationic lipids for siRNA deliverySIRNA THERAPEUTICS INC·Filed 2016·Granted Mar 28, 2017·39 cites·6 claims
- 0397US10072057B2Alternative nucleic acid molecules containing reduced uracil content and uses thereofMODERNATX INC·Filed 2017·Granted Sep 11, 2018·31 cites·21 claims
- 0497US9751925B2Alternative nucleic acid molecules containing reduced uracil content and uses thereofMODERNATX INC·Filed 2015·Granted Sep 5, 2017·32 cites·29 claims
- 0597US9029590B2Low molecular weight cationic lipids for oligonucleotide deliveryCOLLETTI STEVEN L·Filed 2011·Granted May 12, 2015·43 cites·4 claims
- 0696US9458090B2Low molecular weight cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2015·Granted Oct 4, 2016·9 cites·17 claims
- 0796US9402816B2Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2013·Granted Aug 2, 2016·10 cites·7 claims
- 0896US8748667B2Low molecular weight cationic lipids for oligonucleotide deliveryBUDZIK BRIAN W·Filed 2011·Granted Jun 10, 2014·96 cites·3 claims
- 0995US10385088B2Polynucleotide molecules and uses thereofMODERNATX INC·Filed 2014·Granted Aug 20, 2019·66 cites·12 claims
- 1094US9970005B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2015·Granted May 15, 2018·15 cites·41 claims
- 1193US11932854B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2021·Granted Mar 19, 2024·2 cites·25 claims
- 1293US9643916B2Low molecular weight cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2016·Granted May 9, 2017·5 cites·6 claims
- 1393US8835623B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2013·Granted Sep 16, 2014·15 cites·20 claims
- 1493US8802863B2Amino alcohol cationic lipids for oligonucleotide deliveryBUDZIK BRIAN W·Filed 2011·Granted Aug 12, 2014·10 cites·4 claims
- 1593US7544695B2Spirocyclic compoundsMERCK & CO INC·Filed 2006·Granted Jun 9, 2009·29 cites·14 claims
- 1692US9260471B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)CANCILLA MARK·Filed 2011·Granted Feb 16, 2016·60 cites·53 claims
- 1791US11193126B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2018·Granted Dec 7, 2021·7 cites·40 claims
- 1891US8686020B2Spirocyclic compoundsMERCK SHARP & DOHME·Filed 2012·Granted Apr 1, 2014·17 cites·6 claims
- 1991US8518907B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)BROWN DUNCAN·Filed 2011·Granted Aug 27, 2013·16 cites·17 claims
- 2090US10428106B2Phosphate replacement mRNA cap analogsMODERNATX INC·Filed 2018·Granted Oct 1, 2019·4 cites·20 claims
- 2190US9669097B2Low molecular weight cationic lipids for oligonucleotide deliverySTANTON MATTHEW G·Filed 2011·Granted Jun 6, 2017·15 cites·7 claims
- 2290US9062021B2Low molecular weight cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2014·Granted Jun 23, 2015·6 cites·6 claims
- 2390US8026260B2Histone deacetylase inhibitors with aryl-pyrazolyl-motifsMERCK SHARP & DOHME·Filed 2006·Granted Sep 27, 2011·9 cites·15 claims
- 2490US7834026B2Spirocyclic compoundsMERCK SHARP & DOHME·Filed 2006·Granted Nov 16, 2010·17 cites·6 claims
- 2589US10563195B2Phosphate replacement mRNA cap analogsMODERNATX INC·Filed 2018·Granted Feb 18, 2020·4 cites·17 claims
- 2689US9850491B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2016·Granted Dec 26, 2017·5 cites·15 claims
- 2789US9796977B2Low molecular weight cyclic amine containing cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2015·Granted Oct 24, 2017·4 cites·5 claims
- 2889US9642804B2Cationic lipids with various head groups for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2015·Granted May 9, 2017·4 cites·17 claims
- 2988US10570388B2Phosphate replacement MRNA cap analogsMODERNATX INC·Filed 2018·Granted Feb 25, 2020·3 cites·17 claims
- 3088US10532068B2Dual molecular delivery of oligonucleotides and peptide containing conjugatesMERCK SHARP & DOHME·Filed 2018·Granted Jan 14, 2020·3 cites·18 claims
- 3188US9315437B2Low molecular weight cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2015·Granted Apr 19, 2016·3 cites·6 claims
- 3288US2024247271A1Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)SIRNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3387US9446132B2Diether based biodegradable cationic lipids for siRNA deliverySIRNA THERAPEUTICS INC·Filed 2013·Granted Sep 20, 2016·4 cites·7 claims
- 3487US9447420B2RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA)SIRNA THERAPEUTICS INC·Filed 2014·Granted Sep 20, 2016·6 cites·39 claims
- 3585US12263228B2Lipids and compositions thereofGENERATION BIO CO·Filed 2024·Granted Apr 1, 2025·1 cites·30 claims
- 3685US9896688B2Short interfering nucleic acid (siNA) molecules containing a 2′ internucleoside linkageSIRNA THERAPEUTICS INC·Filed 2014·Granted Feb 20, 2018·10 cites·16 claims
- 3785US8461189B2Pyridyl derivatives as histone deacetylase inhibitorsHEIDEBRECHT JR RICHARD W·Filed 2008·Granted Jun 11, 2013·15 cites·19 claims
- 3885US7834034B2Benzothiophene derivativesMERCK SHARP & DOHME·Filed 2006·Granted Nov 16, 2010·9 cites·11 claims
- 3984US10576155B2Low molecular weight cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2017·Granted Mar 3, 2020·3 cites·8 claims
- 4084US9670487B2Cationic lipids for oligonucleotide deliveryCOLLETTI STEVEN L·Filed 2011·Granted Jun 6, 2017·4 cites·7 claims
- 4182US10010562B2Dual molecular delivery of oligonucleotides and peptide containing conjugatesMERCK SHARP & DOHME·Filed 2014·Granted Jul 3, 2018·3 cites·20 claims
- 4281US8389553B24-carboxybenzylamino derivatives as histone deacetylase inhibitorsHARRINGTON PAUL·Filed 2008·Granted Mar 5, 2013·5 cites·2 claims
- 4380US11911475B2Low molecular weight cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2022·Granted Feb 27, 2024·0 cites·8 claims
- 4479US12252470B2Lipids and nanoparticle compositions thereofGENERATION BIO CO·Filed 2024·Granted Mar 18, 2025·0 cites·20 claims
- 4579US9096559B24-carboxybenzylamino derivatives as histone deacetylase inhibitorsHARRINGTON PAUL·Filed 2013·Granted Aug 4, 2015·5 cites·3 claims
- 4679US8158825B2Modified malonate derivativesGRIMM JONATHAN·Filed 2006·Granted Apr 17, 2012·9 cites·17 claims
- 4778US9044512B2Amino alcohol cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2014·Granted Jun 2, 2015·1 cites·8 claims
- 4877US10738308B2Short interfering nucleic acid (siNA) molecules containing a 2′ internucleoside linkage (3dT)SIRNA THERAPEUTICS INC·Filed 2018·Granted Aug 11, 2020·1 cites·14 claims
- 4977US7772238B2Benzothiophene hydroxamic acid derivativesMERCK SHARP & DOHME·Filed 2006·Granted Aug 10, 2010·4 cites·15 claims
- 5077US2025186624A1Polynucleotides containing a stabilizing tail regionMODERNATX INC·Filed 2024·Application pending·0 cites
Showing the top 50 of 104 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Matthew G. Stanton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →